DIETARY_SUPPLEMENT · Unmapped registry intervention
omega-3
Find medicine records ·
Find other trials using this name
Clinical trial
The Impact of Omega-3 Supplementation on Gene Expression in Type 2 Diabetics
NCT01478776
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DIETARY_SUPPLEMENT · Unmapped registry intervention
placebo
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedThe Impact of Omega-3 Supplementation on Gene Expression in Type 2 Diabetics
Design: INTERVENTIONAL · Status: UNKNOWN · Phase: PHASE4
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Interventions
Sponsors & collaborators
Tehran University of Medical Scienceslead sponsor
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01478776 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.